Form 4: Travere Therapeutics Director, Suzanne Bruhn, Reports Acquisition of Shares and Stock Options

Director Suzanne Bruhn reported acquiring 6,500 shares of common stock and 19,500 stock options in Travere Therapeutics, Inc. on May 8, 2024, as part of the company's equity incentive plan.

Summary

• On May 8, 2024, Suzanne Louise Bruhn, a director of Travere Therapeutics, Inc., acquired 6,500 shares of common stock.
• These shares were acquired at a price of $0.
• Bruhn also acquired 19,500 stock options with an exercise price of $6.82.
• These options vest over a one-year period and expire on May 7, 2034.
• Following these transactions, Bruhn directly owns 19,500 derivative securities and 22,250 shares of common stock.
• The acquisitions were made under Travere Therapeutics' Equity Incentive Plan as part of the non-employee director compensation program.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The director's acquisition of shares and options indicates confidence in the company. The grant is part of a standard compensation plan.

Positives

• The acquisition of shares and options by a director signals confidence in the company's future.
• The equity award vests over a one-year period, incentivizing the director to contribute to the company's success over that time.

Future Outlook

The document does not contain specific forward-looking statements, but the equity grant suggests an ongoing relationship between the director and the company.

Industry Context

Director compensation through equity grants is a common practice in the pharmaceutical industry to align the interests of directors with those of shareholders.

Comparison to Industry Standards

• Equity grants to non-employee directors are a standard practice across the pharmaceutical and biotechnology industries.
• Companies like BioMarin Pharmaceutical Inc. and Vertex Pharmaceuticals Incorporated also utilize equity-based compensation for their board members.
• The size and vesting schedule of the grant are typical for director compensation packages in similar-sized companies.

Stakeholder Impact

• The equity grant aligns the director's interests with those of shareholders, potentially leading to better corporate governance and decision-making.
• Employees may view the equity grant positively, as it signals confidence in the company's future.

Key Dates